NCT02783183View on ClinicalTrials.gov

A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

November 30, 2016

Conditions
Peripheral Nueropathy Pain
Interventions
DRUG

YHD1119

2 by 2

DRUG

Lyrica

2 by 2

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT02783183 - A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin | Biotech Hunter | Biotech Hunter